Pro-oncogenic effects of EphA2 in cancer cells are mainly orchestrated through ligand-independent activation of EphA2, and the presence of exogenous ephrinA1 induces EphA2 internalization and degradation and reduces its oncogenic signaling [22]. This evidence concerns the gene EPHA2 and cancer.